Menopause

Reproductive·MeSH: Motor Activity

13 drugs in development·9 companies·7 clinical trials

Drug Pipeline by Phase

Approved(6)

Drug	Company
bijuva	TherapeuticsMD, Inc. (TXMD)
elestrin	Viatris Inc (VTRS)
estradiol	Mylan II B.V. (MYL)
estradiol	Amneal Pharmaceuticals, Inc. (AMRX)
huoliyuan	SPRING PHARMACEUTICAL GROUP, INC. (CYIG)
imvexxy	TherapeuticsMD, Inc. (TXMD)

Phase 2(5)

Drug	Company
Anti-hypertensives	CYTOKINETICS INC (CYTK)
Fezolinetant	CYTOKINETICS INC (CYTK)
Lipid Lowering Medication	CYTOKINETICS INC (CYTK)
ph80	Vistagen Therapeutics, Inc. (VTGN)
semaglutide	CYTOKINETICS INC (CYTK)

Unknown(1)

Drug	Company
Medical formulations portfolio	Cannabis Bioscience International Holdings, Inc. (CBIH)

Phase 1/Phase 2(1)

Drug	Company
ABCL635	AbCellera Biologics Inc. (ABCL)

BioSniper tracks 13 drugs in development for Menopause across 9 companies.

There are 7 clinical trials targeting Menopause tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.